Soliton — Technical Presentation (June 2020)
29 slides from Soliton's technical presentation, Jun 15, 2020
Slide 1: Improvement in the Appearance of Cellulite Resulting from a Single Treatment with Acoustic Subcision
Improvement in the Appearance of Cellulite Resulting from a Single Treatment with Acoustic Subcision: Findings from a Multi-Center Pivotal Trial Elizabeth L. Tanzi, M.D. FAAD Associate Clinical Professor of Dermatology George Washington University School of Medicine Washington, DC Director Capital L
Slide 2: Disclosure
Disclosure • Allergan/Coolsculpting (SAB) • Beiersdorf • Cutera • Merz/Ulthera • Pulse Biosciences (SAB) • Sciton (SAB) • Soliton (SAB) • Solta • Syneron/Candela
Slide 3: Cellulite and Acoustic Subcision
Cellulite and Acoustic Subcision Cellulite Dimples Acoustic Subcision Smooth Epidermis Dermis Rapid Acoustic Pulses Fat cells Ruptured Fibrous septa fibrous septa Septa can contract and become sclerotic Rapid Acoustic Pulse (RAP) device emits rapid holding portions of the skin with a non- acoustic p
Slide 4: Rapid Acoustic Pulse
Rapid Acoustic Pulse Repetition rate and very short rise time provide microscopic mechanical disruption to the targeted cellular level structures and vacuoles High peak pressure and fast repetition rate exploit viscoelastic nature of tissue Compressed pulses from electronic filtering and reflector s
Slide 5: Acoustic Disruption of Septa – Time/Dose Response
Acoustic Disruption of Septa – Time/Dose Response #
Slide 6: Acoustic subcision device: Procedure
Acoustic subcision device: Procedure ! 20-30-minute procedure can treat much of a single leg/buttock area ! Non-invasive: Real “incision-less” procedure. Skin never punctured ! No anesthetic required ! Physician oversight of delivery; delegable ! No recovery time $
Slide 7: Improvement in the Appearance of Cellulite Resulting from a Single Treatment: Multi-Center Pivotal Trial
Improvement in the Appearance of Cellulite Resulting from a Single Treatment with Acoustic Subcision Device: Findings from a Multi-Center Pivotal Trial Clinical Trial Sites Elizabeth Tanzi, MD Michael Kaminer, MD Brenda LaTowsky, MD Omer Ibrahim, MD Capital Laser & Skin Care SkinCare Physicians Clea
Slide 8: Results Summary – Participants
RESULTS SUMMARY -- PARTICIPANTS !"#$%&'()!*(+&%)+#%!+' !"#$%%&' !"#$%%&'()"'(*#&)*&' ,- +$,* +$,*(*$(-$%%$./01($#(&23%0,4$")#5(3#4*) . !6)%0)*&' !6)%0)*&'()*(78/.&&9, ,/ :3$0,*43(;0<34,4$"(;&,,4$" =4"0*&,(>=&)"((? ,*'(@ /012 ? ABC 34)&)3+%&5'+53' D&"'&# E&F)%& 6778 G)3& HI4*&JK)03),4)" 96198 :-#4
Slide 9: Results Summary: Efficacy – Cellulite
RESULTS SUMMARY: EFFICACY--CELLULITE 3%;;";5+%(5#<&=>%#%!+(? $@ABCDC(<EFGAHAIB(()GGDGGJDBK G&,1$"'&#, R(S&F$",*#)*&'(K;;(G&'03*4$"(( 0-168 R('&F$",*#)*4"O T(8UR((=&)"(K;;(G&'03*4$"(( -6178 T(AUR((=&)"(K;;(G&'03*4$"(( .,1.8 T(VUR((=&)"(K;;(G&'03*4$"(( /:1/8 W6&#)%%((!--43)35( L),&%4"&(K;;(;3$#&(>=&)"
Slide 10: Results Summary: Safety, Tolerability and Satisfaction
RESULTS SUMMARY: SAFETY, TOLERABILITY AND SATISFACTION &%'";+'('"##)&LM(')N%+LO(+=;%&)$5;5+L()!*( ')+5'N)3+5=! ')N%+L !21&3*&'(:!, R(1)#*4341)"*,(((>=4"4F)%($#(F4%'( *I&F)\( 9.1/8 -$%%430%4*4,\(10#10#)($#(1)4"@ ^"&21&3*&'(:!,( R(1)#*4341)"*,(( 7178 ;$0,(:!, R(1)#*4341)"*,(( 7178 +=;%&)$5;5+L
Slide 11: !"#$%&' ("!)*+,+ ("!) &-./ : ; !"#$%&'()* +,-%./0%(1!!(234 6(7%%8-(1!!(63**(
!"#$%&' ("!)*+,+ ("!) &-./ : ; !"#$%&'()* +,-%./0%(1!!(234 56(7%%8-(1!!(63**(
Slide 12: !"#$%&' ("!)*+,0 ("!) &-,+ : ; !"#$%&'()* +,-%./0%(1!!(234 6(7%%8-((1!!(63**(
!"#$%&' ("!)*+,0 ("!) &-,+ : ; !"#$%&'()* +,-%./0%(1!!(234 56(7%%8-((1!!(63**(
Slide 13: !"#$%&' ("!)*+,, ("!)&-,# : ; !"#$%&'()* +,-%./0%(1!!(234 (7%%8-((1!!(63**(
!"#$%&' ("!)*+,, ("!)&-,# : ; !"#$%&'()* +,-%./0%(1!!(234 56(7%%8-((1!!(63**(
Slide 14: !"+%+, ("!)+,,0 ("!)/+,* : ; !"#$%&'(69 +,-%./0%(1!!(*3): (7%%8-((1!!(53):(
!"+%+, ("!)+,,0 ("!)/+,* : ; !"#$%&'(69 +,-%./0%(1!!(*3): 56(7%%8-((1!!(53):(
Slide 15: !"+%+, ("!)+,0& ("!)/+,/ : ; !"#$%&'(69 +,-%./0%(1!!(*3): (7%%8-((1!!(53):(
!"+%+, ("!)+,0& ("!)/+,/ : ; !"#$%&'(69 +,-%./0%(1!!(*3): 56(7%%8-((1!!(53):(
Slide 16: !"+%+, ("!)+,0/ ("!)/+0* : ; !"#$%&'(69 +,-%./0%(1!!(*3): (7%%8-((1!!(53):(
!"+%+, ("!)+,0/ ("!)/+0* : ; !"#$%&'(69 +,-%./0%(1!!(*3): 56(7%%8-((1!!(53):(
Slide 17: !"#$%/. ("!)*-#+ ("!)&#'* : ; !"#$%&'(2: +,-%./0%(1!!(2344 6(7%%8-((1!!(*344(
!"#$%/. ("!)*-#+ ("!)&#'* : ; !"#$%&'(2: +,-%./0%(1!!(2344 56(7%%8-((1!!(*344(
Slide 18: !"#$%/. ("!)*-#+ ("!)&#'* : ; !"#$%&'(2: +,-%./0%(1!!(2344 6(7%%8-((1!!(*344(
!"#$%/. ("!)*-#+ ("!)&#'* : ; !"#$%&'(2: +,-%./0%(1!!(2344 56(7%%8-((1!!(*344(
Slide 19: !"#$%/. ("!)*-#* ("!)&#'& : ; !"#$%&'(2: +,-%./0%(1!!(2344 6(7%%8-((1!!(*344(
!"#$%/. ("!)*-#* ("!)&#'& : ; !"#$%&'(2: +,-%./0%(1!!(2344 56(7%%8-((1!!(*344(
Slide 20: !"#$%/. ("!)*-#/ ("!)&#'. : ; !"#$%&'(2: +,-%./0%(1!!(2344 6(7%%8-((1!!(*344(
!"#$%/. ("!)*-#/ ("!)&#'. : ; !"#$%&'(2: +,-%./0%(1!!(2344 56(7%%8-((1!!(*344(
Slide 21: '@ACDM(,/ !"#$%&+ ("!)*+', ("!)�* : ; !"#$%&'()6 +,-%./0%(1!!(2344 56(7%%8-((1!!(63**(
'@ACDM(,/ !"#$%&+ ("!)*+', ("!)�* : ; !"#$%&'()6 +,-%./0%(1!!(2344 56(7%%8-((1!!(63**(
Slide 22: '@ACDM(,/ !"#$%&+ ("!)*+'0 ("!)�/ : ; !"#$%&'()6 +,-%./0%(1!!(2344 56(7%%8-((1!!(63**(
'@ACDM(,/ !"#$%&+ ("!)*+'0 ("!)�/ : ; !"#$%&'()6 +,-%./0%(1!!(2344 56(7%%8-((1!!(63**(
Slide 23: !"+%#, ("!)+..+ ("!)*.#* : ; !"#$%&'(59 +,-%./0%(1!!(63** (7%%8-((1!!(43**(
!"+%#, ("!)+..+ ("!)*.#* : ; !"#$%&'(59 +,-%./0%(1!!(63** 56(7%%8-((1!!(43**(
Slide 24: !"+%#, ("!)+..' ("!)*.#/ : ; !"#$%&'(59 +,-%./0%(1!!(63** (7%%8-((1!!(43**(
!"+%#, ("!)+..' ("!)*.#/ : ; !"#$%&'(59 +,-%./0%(1!!(63** 56(7%%8-((1!!(43**(
Slide 25: !"#$%&'( )"!*'+'& )"!*,'-+ : ; !"#$%&'(;4 +,-%./0%(1!!(*3): 56(7%%8-((1!!(63**(
!"#$%&'( )"!*'+'& )"!*,'-+ : ; !"#$%&'(;4 +,-%./0%(1!!(*3): 56(7%%8-((1!!(63**(
Slide 26: !"#$%&'( )"!*'+'# )"!*,'-, : ; !"#$%&'(;4 +,-%./0%(1!!(*3): 56(7%%8-((1!!(63**(
!"#$%&'( )"!*'+'# )"!*,'-, : ; !"#$%&'(;4 +,-%./0%(1!!(*3): 56(7%%8-((1!!(63**(
Slide 27: !"'1%*# ("!)-.*/ ("!)/&+, : ; !"#$%&'(;5 +,-%./0%(1!!(2344 6(7%%8-((1!!(*344(
!"'1%*# ("!)-.*/ ("!)/&+, : ; !"#$%&'(;5 +,-%./0%(1!!(2344 56(7%%8-((1!!(*344(
Slide 28: !"'1%*#2 ("!)-.*' ("!)/&+. : ; !"#$%&'(;5 +,-%./0%(1!!(2344 56(7%%8-((1!!(*344(
!"'1%*#2 ("!)-.*' ("!)/&+. : ; !"#$%&'(;5 +,-%./0%(1!!(2344 56(7%%8-((1!!(*344(
Slide 29: Summary
Summary • Acoustic Subcision represents a novel, non-invasive treatment to improve the appearance of cellulite • At 12-weeks, a single 20 to 30-minute acoustic subcision treatment provided a 1.16-point reduction in the CSS. On average, this represented a 32.5% reduction from the participants baselin